| abstract |
This invention comprising a single or plural strains of Lactobacillus having special characteristics that have been never known is a new type of pharmaceutical Lactobacillus preparation for the treatment of infectious diseases. Some of the characteristics of Lactobacillus used for the present invention as as follows. (a) They are able to grow in low nutrition. (b) The speed of multiplication is quick. (c) By odoriferous S-, N- & C-compound, is promoted the growth. The effects of the present invention are as follows. Unlike the antibiotics which serves only to kill the bacteria, the present preparation is characteristic in that (a) it is non-pathogenic; (b) it can produce antibiotics thereby killing bacteria; (c) it can survive in the growth competition with pathogenic or other bacteria; (d) it denatures the metabolites (including poisonous ones) of living bodies or convert them into constituents of its own cells; (e) it purifies an affected part; (f) it shows anti-inflammatory or anti-swelling activities; and finally (g), as said preparation is foreign to the living bodies and is non-pathogenic, it is at least digested after the inflammatory diseases disappear. Accordingly, the present invention can be used extensively to give better therapeutic effects, except where the physical structure does not permit to use it. |